Neuralgia Clinical Trial
Official title:
Somatosensory Investigation of Orofacial Pain Patients
Orofacial pain, specially neuropathic orofacial pain, is a challenge of diagnosis and treatment in orofacial pain. It is associated with sensory abnormalities.With increasing life expectancy of the population is more and more common to find individuals with chronic diseases however, there is little evidence about the influence of comorbidities and medications in use on sensory thresholds of neuropathic orofacial pain. Objective: to investigate the influence of comorbidities and medication in somatosensory function of patients with orofacial neuropathic pain compared to controls.In this case-control study, 336 orofacial pain patients and controls were recruited from the Hospital das Clinicas da Faculdade de Medicina da USP were investigated about comorbidities, use of chronic medication, pain characteristics and a detailed standardized protocol of somatosensory evaluation at the trigeminal territories for cold, warm, tactile, vibration, deep, superficial and electric pain thresholds.
Comorbidities The patients were interviewed by the same orofacial pain specialist using a
questioner at the moment of the quantitative sensitive test.
Orofacial evaluation Instruments for orofacial evaluation. The questionnaires and exams were
performed by one researcher only, a dentist, who ensured the clear understanding of the
content by the participants before starting the protocol. All subjects underwent a
standardized protocol for the evaluation of the orofacial region, including main complaint,
pain characteristics [location, quality, duration, descriptors, intensity by the Visual
Analog Scale (VAS), alleviation and aggravation factors], earache, headache, generalized body
pain, sleep disturbances. Masticatory complaints related to parafunctional habits, laterality
and the quality of mastication were also investigated. The intensity of masticatory
discomfort was evaluated with the VAS. The intraoral examination included the evaluation of
teeth, periodontal tissues, oral mucosa, tongue, lips, and facial skin, prostheses, occlusion
and functional aspects, such as mandibular movements (mouth opening, protrusion, laterality)
and temporomandibular joint (TMJ) exam (noises, spontaneous pain, or pain concomitant with
movements). The muscular palpation of the head and neck was performed at the bilateral
masseter, temporalis, digastrics, sternocleidomastoid, trapezius, splenius and suboccipitals.
The periodontal exam was performed with adequate probes and the diagnoses made in accordance
to the criteria of the American Academy of Periodontology. All participants underwent this
detailed investigation for differential diagnosis with dental pain etiologies. Previous
studies have shown that they can be associated with the main diagnosis of the patients.
Sensory investigation All subjects were interviewed about their perception of sensorial
abnormalities such as numbness, dysesthesia, taste and smell complaints. The frequency of
these abnormalities (absent, eventual, frequent, or constant) and the intensity (0-10 by VAS)
were analyzed. This protocol is important for neuropathic and non-neuropathic pain diseases
because somatic pain also presents sensitization and chronification.
QST. All subjects underwent a standardized protocol of QST which consists of 8 tests grouped
as follows:
- gustative and olfactory thresholds;
- thermal detection thresholds for cold and warm sensations;
- mechanical detection thresholds for touch and vibration;
- mechanical pain sensitivity including superficial and deep pain thresholds. The
somatosensory testing was performed at the 3 trigeminal branches (ophthalmic: fronte2 cm
above the pupil, maxillary: cheek e 1 cm lateral to the nose wing, and mandibular: chin
skin e 1 cm below the lip angle), at the hand dorsum (1 cm lateral to the thumb basis)
and the anterior tibia skin (10 cm below the basis of patella). The evaluation was
performed bilaterally in all subjects. All subjects were evaluated in the sitting
position, with the head resting at a flat surface, and in a silent room with acoustic
protection and the door closed. Only the participant and the researcher were in the
room. All subjects were evaluated by the same researcher. The participants were oriented
to keep the eyes closed during the exam, to be focused on the stimuli, and to their
location (face and mouth) and characteristics. Only the researcher knew the order of the
stimuli. Gustative thresholds: the following four substances, corresponding to the 4
tastes, were tested. For each test, one drop was applied at the tongue, starting with
the low concentration, interleaved with one drop of distillate water, and the
concentrations were tested until the subject had detected and identified the stimulus.
Sweet: glucose (0.01 M; 0.032 M; 0.1 M; 0.32 M; 1.0 M); Salty: sodium chloride (0.01 M; 0.032
M; 0.1 M; 0.32 M;1.0 M); Sour: citric acid (0.00032 M; 0.001 M; 0.0032 M;0.01 M; 0.032 M);
Bitter: urea (0.1 M; 0.32 M; 1.0 M;3.2 M; 10.0 M). Olfactory thresholds: the subjects were
evaluated with isopropanol solutions in polyethylene bottles interleaved with distillate
water, starting with the lowconcentration until the subject had detected the stimulus;0.09%,
13.0%, 23.0%, 35.0%, 53.0%, 70.0%.
Thermal detection: thermal testing was performed using the MSA thermo test device (Somedic,
Sweden). The baseline temperature was 32°C and the contact square area of the thermode was 9
x 9 mm. Cold detection threshold and warm detection threshold were assessed using ramped
stimuli 1°C/s. The evaluation consisted in 5 measurements for each thermal threshold, and the
means and standard deviations were considered for the analysis.
Mechanical detection threshold: touch perception was assessed using a set of standardized von
Frey filaments with rounded tips of 0.5 mm diameter, applied with an electronic device (IITC,
Woodland Hills, CA, USA). Three measurements in g/mm2 were performed and the means and SDs
were considered for the analysis.
Vibration detection threshold: vibration testing was was performed using the electronic
Vibrameter device(Somedic, Sweden) with a vibrator of 650 g of weight and a contact area of 1
cm2 perpendicularly applied for the thresholds detection, using ramped stimuli of 1 Hz/s. The
method of calculation of vibration threshold consisted in the mean between the appearance and
disappearance thresholds detected by the patient.
Pressure pain perception: deep pain thresholds were measured with the electronic pressure
algometer (Somedic, Sweden) with a probe area of 1 cm2 which was pressed on the skin with a
ramp rate of 50 kPa/s. Superficial pain perception: superficial pain thresholds were
determined using disposable needles of 8x10x0.5 mm, applied with an electronic device (IITC,
Woodland Hills, CA, USA). Three measurements in g/mm2 were performed and the means and SDs
were considered for the analysis.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04066933 -
Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M
|
||
Completed |
NCT01202227 -
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
|
Phase 3 | |
Completed |
NCT00922987 -
Clinical Study With Lyrica In Patients Suffering From Epilepsy
|
||
Terminated |
NCT00964990 -
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
|
Phase 2 | |
Recruiting |
NCT00740571 -
Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer
|
Phase 3 | |
Terminated |
NCT02747758 -
Transcranial Direct Current Stimulation (tDCS) in Chronic Neuropathy
|
N/A | |
Completed |
NCT05464199 -
Home-based EEG Neurofeedback for Chronic Neuropathic Pain
|
Phase 1 | |
Completed |
NCT02490436 -
Novel Treatment Option for Neuropathic Pain
|
Phase 2 | |
Completed |
NCT01974791 -
GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT01279018 -
Persistent Pain After Breast Cancer Treatment With Docetaxel
|
N/A | |
Not yet recruiting |
NCT00944502 -
To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins
|
Phase 3 | |
Completed |
NCT02957851 -
EMONO for the Treatment of Peripheral Neuropathic Pain
|
Phase 2 | |
Completed |
NCT02180880 -
Symptom Based Treatment of Neuropathic Pain
|
Phase 4 | |
Active, not recruiting |
NCT01508676 -
Effects of Pennsaid on Clinical Neuropathic Pain
|
N/A | |
Completed |
NCT00631943 -
A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain
|
Phase 3 | |
Completed |
NCT03973983 -
Comparison of Ultrasound-guided Transgluteal and Finger-guided Transvaginal Pudendal Nerve Block Techniques
|
N/A | |
Terminated |
NCT03296111 -
Patients With Ocular Neuropathic Pain: Description of Pain and Impact on Their Quality of Life
|
||
Not yet recruiting |
NCT06398847 -
Virtual Reality (VR) Self-Hypnosis Software
|
N/A | |
Terminated |
NCT02460107 -
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
|
Early Phase 1 | |
Recruiting |
NCT01788410 -
MRI-Guided Cryoablation to Alleviate Pain in Head, Neck and Spine
|